The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Montelukast API-Global Market Insights and Sales Trends 2024
Synopsis
The global Montelukast API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Montelukast API in various end use industries. The expanding demands from the Asthma, Allergic Rhinitis, Urticaria and Bronchospasm, are propelling Montelukast API market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chewable Tablet segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Montelukast API market, driven by demand from China, the second largest economy with some signs of stabilising, the Montelukast API market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Montelukast API, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Montelukast API market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Montelukast API market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Montelukast API sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Montelukast API covered in this report include Merck, Cipla, Morepen Laboratories, Sun Pharma, Teva Pharmaceutical Industries, Intas Pharmaceuticals, Apotex, Sanyo Chemical Industries and Mylan, etc.
The global Montelukast API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Cipla
Morepen Laboratories
Sun Pharma
Teva Pharmaceutical Industries
Intas Pharmaceuticals
Apotex
Sanyo Chemical Industries
Mylan
Delmar Chemicals
Global Montelukast API market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Montelukast API market, Segment by Type:
Tablet
Chewable Tablet
Oral Solution
Global Montelukast API market, by Application
Asthma
Allergic Rhinitis
Urticaria
Bronchospasm
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Montelukast API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Montelukast API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Montelukast API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Montelukast API in various end use industries. The expanding demands from the Asthma, Allergic Rhinitis, Urticaria and Bronchospasm, are propelling Montelukast API market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chewable Tablet segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Montelukast API market, driven by demand from China, the second largest economy with some signs of stabilising, the Montelukast API market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Montelukast API, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Montelukast API market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Montelukast API market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Montelukast API sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Montelukast API covered in this report include Merck, Cipla, Morepen Laboratories, Sun Pharma, Teva Pharmaceutical Industries, Intas Pharmaceuticals, Apotex, Sanyo Chemical Industries and Mylan, etc.
The global Montelukast API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Cipla
Morepen Laboratories
Sun Pharma
Teva Pharmaceutical Industries
Intas Pharmaceuticals
Apotex
Sanyo Chemical Industries
Mylan
Delmar Chemicals
Global Montelukast API market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Montelukast API market, Segment by Type:
Tablet
Chewable Tablet
Oral Solution
Global Montelukast API market, by Application
Asthma
Allergic Rhinitis
Urticaria
Bronchospasm
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Montelukast API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Montelukast API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Montelukast API Market Overview
1.1 Montelukast API Product Overview
1.2 Montelukast API Market Segment by Type
1.2.1 Tablet
1.2.2 Chewable Tablet
1.2.3 Oral Solution
1.3 Global Montelukast API Market Size by Type
1.3.1 Global Montelukast API Market Size Overview by Type (2018-2029)
1.3.2 Global Montelukast API Historic Market Size Review by Type (2018-2023)
1.3.3 Global Montelukast API Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Montelukast API Sales Breakdown by Type (2018-2023)
1.4.2 Europe Montelukast API Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Montelukast API Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Montelukast API Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Montelukast API Sales Breakdown by Type (2018-2023)
2 Global Montelukast API Market Competition by Company
2.1 Global Top Players by Montelukast API Sales (2018-2023)
2.2 Global Top Players by Montelukast API Revenue (2018-2023)
2.3 Global Top Players by Montelukast API Price (2018-2023)
2.4 Global Top Manufacturers Montelukast API Manufacturing Base Distribution, Sales Area, Product Type
2.5 Montelukast API Market Competitive Situation and Trends
2.5.1 Montelukast API Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Montelukast API Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Montelukast API as of 2022)
2.7 Date of Key Manufacturers Enter into Montelukast API Market
2.8 Key Manufacturers Montelukast API Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Montelukast API Status and Outlook by Region
3.1 Global Montelukast API Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Montelukast API Historic Market Size by Region
3.2.1 Global Montelukast API Sales in Volume by Region (2018-2023)
3.2.2 Global Montelukast API Sales in Value by Region (2018-2023)
3.2.3 Global Montelukast API Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Montelukast API Forecasted Market Size by Region
3.3.1 Global Montelukast API Sales in Volume by Region (2024-2029)
3.3.2 Global Montelukast API Sales in Value by Region (2024-2029)
3.3.3 Global Montelukast API Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Montelukast API by Application
4.1 Montelukast API Market Segment by Application
4.1.1 Asthma
4.1.2 Allergic Rhinitis
4.1.3 Urticaria
4.1.4 Bronchospasm
4.1.5 Others
4.2 Global Montelukast API Market Size by Application
4.2.1 Global Montelukast API Market Size Overview by Application (2018-2029)
4.2.2 Global Montelukast API Historic Market Size Review by Application (2018-2023)
4.2.3 Global Montelukast API Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Montelukast API Sales Breakdown by Application (2018-2023)
4.3.2 Europe Montelukast API Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Montelukast API Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Montelukast API Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Montelukast API Sales Breakdown by Application (2018-2023)
5 North America Montelukast API by Country
5.1 North America Montelukast API Historic Market Size by Country
5.1.1 North America Montelukast API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Montelukast API Sales in Volume by Country (2018-2023)
5.1.3 North America Montelukast API Sales in Value by Country (2018-2023)
5.2 North America Montelukast API Forecasted Market Size by Country
5.2.1 North America Montelukast API Sales in Volume by Country (2024-2029)
5.2.2 North America Montelukast API Sales in Value by Country (2024-2029)
6 Europe Montelukast API by Country
6.1 Europe Montelukast API Historic Market Size by Country
6.1.1 Europe Montelukast API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Montelukast API Sales in Volume by Country (2018-2023)
6.1.3 Europe Montelukast API Sales in Value by Country (2018-2023)
6.2 Europe Montelukast API Forecasted Market Size by Country
6.2.1 Europe Montelukast API Sales in Volume by Country (2024-2029)
6.2.2 Europe Montelukast API Sales in Value by Country (2024-2029)
7 Asia-Pacific Montelukast API by Region
7.1 Asia-Pacific Montelukast API Historic Market Size by Region
7.1.1 Asia-Pacific Montelukast API Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Montelukast API Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Montelukast API Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Montelukast API Forecasted Market Size by Region
7.2.1 Asia-Pacific Montelukast API Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Montelukast API Sales in Value by Region (2024-2029)
8 Latin America Montelukast API by Country
8.1 Latin America Montelukast API Historic Market Size by Country
8.1.1 Latin America Montelukast API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Montelukast API Sales in Volume by Country (2018-2023)
8.1.3 Latin America Montelukast API Sales in Value by Country (2018-2023)
8.2 Latin America Montelukast API Forecasted Market Size by Country
8.2.1 Latin America Montelukast API Sales in Volume by Country (2024-2029)
8.2.2 Latin America Montelukast API Sales in Value by Country (2024-2029)
9 Middle East and Africa Montelukast API by Country
9.1 Middle East and Africa Montelukast API Historic Market Size by Country
9.1.1 Middle East and Africa Montelukast API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Montelukast API Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Montelukast API Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Montelukast API Forecasted Market Size by Country
9.2.1 Middle East and Africa Montelukast API Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Montelukast API Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Montelukast API Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Montelukast API Products Offered
10.1.5 Merck Recent Development
10.2 Cipla
10.2.1 Cipla Company Information
10.2.2 Cipla Introduction and Business Overview
10.2.3 Cipla Montelukast API Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Cipla Montelukast API Products Offered
10.2.5 Cipla Recent Development
10.3 Morepen Laboratories
10.3.1 Morepen Laboratories Company Information
10.3.2 Morepen Laboratories Introduction and Business Overview
10.3.3 Morepen Laboratories Montelukast API Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Morepen Laboratories Montelukast API Products Offered
10.3.5 Morepen Laboratories Recent Development
10.4 Sun Pharma
10.4.1 Sun Pharma Company Information
10.4.2 Sun Pharma Introduction and Business Overview
10.4.3 Sun Pharma Montelukast API Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sun Pharma Montelukast API Products Offered
10.4.5 Sun Pharma Recent Development
10.5 Teva Pharmaceutical Industries
10.5.1 Teva Pharmaceutical Industries Company Information
10.5.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.5.3 Teva Pharmaceutical Industries Montelukast API Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Teva Pharmaceutical Industries Montelukast API Products Offered
10.5.5 Teva Pharmaceutical Industries Recent Development
10.6 Intas Pharmaceuticals
10.6.1 Intas Pharmaceuticals Company Information
10.6.2 Intas Pharmaceuticals Introduction and Business Overview
10.6.3 Intas Pharmaceuticals Montelukast API Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Intas Pharmaceuticals Montelukast API Products Offered
10.6.5 Intas Pharmaceuticals Recent Development
10.7 Apotex
10.7.1 Apotex Company Information
10.7.2 Apotex Introduction and Business Overview
10.7.3 Apotex Montelukast API Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Apotex Montelukast API Products Offered
10.7.5 Apotex Recent Development
10.8 Sanyo Chemical Industries
10.8.1 Sanyo Chemical Industries Company Information
10.8.2 Sanyo Chemical Industries Introduction and Business Overview
10.8.3 Sanyo Chemical Industries Montelukast API Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanyo Chemical Industries Montelukast API Products Offered
10.8.5 Sanyo Chemical Industries Recent Development
10.9 Mylan
10.9.1 Mylan Company Information
10.9.2 Mylan Introduction and Business Overview
10.9.3 Mylan Montelukast API Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Mylan Montelukast API Products Offered
10.9.5 Mylan Recent Development
10.10 Delmar Chemicals
10.10.1 Delmar Chemicals Company Information
10.10.2 Delmar Chemicals Introduction and Business Overview
10.10.3 Delmar Chemicals Montelukast API Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Delmar Chemicals Montelukast API Products Offered
10.10.5 Delmar Chemicals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Montelukast API Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Montelukast API Industrial Chain Analysis
11.4 Montelukast API Market Dynamics
11.4.1 Montelukast API Industry Trends
11.4.2 Montelukast API Market Drivers
11.4.3 Montelukast API Market Challenges
11.4.4 Montelukast API Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Montelukast API Distributors
12.3 Montelukast API Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
